Levetiracetam

被引：0
|
作者：
不详
机构：
来源：
DRUGS OF THE FUTURE | 2002年 / 27卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Levetiracetam (Keppra(R)), developed by UCB, was approved in the U.S. in 1999 as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy. It is also approved in several European countries. Lundbeck holds marketing rights to the drug in Canada, where it is under review by the regulatory authorities (1). The drug is also under evaluation for the treatment of neuropathic pain and migraine.
引用
收藏
页码：419 / 420
页数：2
相关论文
共 50 条
  • [31] Safety profile of levetiracetam
    Harden, C
    EPILEPSIA, 2001, 42 : 36 - 39
  • [32] Levetiracetam Induced Thrombocytopenia
    Sahaya, Kinshuk
    Goyal, Munish K.
    Sarwal, Aarti
    Singh, Niranjan N.
    NEUROLOGY, 2010, 74 (09) : A457 - A457
  • [33] Levetiracetam in childhood epilepsy
    Verrotti A.
    D'Adamo E.
    Parisi P.
    Chiarelli F.
    Curatolo P.
    Pediatric Drugs, 2010, 12 (3) : 177 - 186
  • [34] Levetiracetam as migraine prophylaxis
    Cochran, JW
    CLINICAL JOURNAL OF PAIN, 2004, 20 (03): : 198 - 199
  • [35] Antimyoclonic effect of levetiracetam
    Genton, P
    Gélisse, P
    EPILEPTIC DISORDERS, 2000, 2 (04) : 209 - 212
  • [36] A cognitive study on levetiracetam
    Piazzini, A.
    Chifari, R.
    Turner, K.
    Canevini, M. P.
    Canger, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 82 - 82
  • [37] Levetiracetam/PhenobarbitalLack of efficacy
    Reactions Weekly, 2024, 2006 (1) : 368 - 368
  • [38] Levetiracetam for epilepsy patients
    Goulding, P.
    Geldard, J.
    Basu, R.
    EPILEPSIA, 2007, 48 : 63 - 63
  • [39] Levetiracetam: treatment in epilepsy
    Ben-Menachem, E
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (11) : 2079 - 2088
  • [40] Levetiracetam—induced hyponatremia
    Elena Cecilia Rosca
    Mihaela Simu
    Acta Neurologica Belgica, 2018, 118 : 123 - 124
12345